美国大型医疗系统编码分析:干眼病患病率与发病率估算
总体患病率为5.28%,女性7.78%、男性2.96%,并随年龄升高;年度患病率与发病率在研究期间各人群均上升。
要点
- 总体干眼病患病率5.28%,女性高于男性(7.78%对2.96%)。
- 患病率随年龄升高,2-17岁为0.20%,50岁以上达11.66%。
- 年度患病率与发病率在研究期间各人群均呈上升趋势。
核心结论
- 干眼病总体患病率、年度患病率与发病率在所有人群中随时间上升,提示该常见病的研究与治疗开发仍具重要性。
主要发现
- 总体患病率为5.28%,女性受益人7.78%,男性受益人2.96%。
- 患病率随年龄从2-17岁的0.20%升至50岁以上的11.66%。
- 年度患病率总体从0.8%升至3.0%,女性从1.4%升至4.5%,男性从0.3%升至1.6%。
- 年度患病率按年龄从18-39岁的0.1%-0.6%升至50岁以上的1.8%-6.0%。
- 年度发病率总体从0.6%升至0.9%,女性从0.8%升至1.2%,男性从0.3%升至0.6%;按年龄从18-39岁的0.2%-0.3%升至50岁以上的1.0%-1.6%。
关键数值与推荐
- 干眼病识别采用诊断编码与环孢素眼用乳剂处方相结合的算法。
- 患病率按性别、年龄组及ICD-9诊断编码分组进行分层。
临床怎么用
- 提示临床关注女性及50岁以上人群的干眼病高负担,并在诊疗中重视该病的长期增长趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess overall prevalence, annual prevalence, and incidence of dry eye disease (DED) in a large, representative population in the United States. DESIGN: Prevalence and incidence study. METHODS: Retrospective analysis using the Department of Defense (DOD) Military Health System (MHS) data on beneficiary medical claims from United States DOD military and civilian facilities, January 1, 2003 through March 31, 2015. PATIENT POPULATION: Using an algorithm, medical diagnostic codes indicative of DED and prescriptions for cyclosporine ophthalmic emulsion identified a DED population from 9.7 million MHS beneficiaries (DOD service members, retirees, and dependents, aged 2-80+ years). MAIN OUTCOME MEASURES: DED overall prevalence (2003-2015), annual prevalence (2005-2012), and annual incidence (2008-2012) stratified by sex, age group, and International Statistical Classification of Diseases and Related Health Problems, Ninth Revision diagnosis code grouping. RESULTS: DED prevalence was 5.28% overall, 7.78% among female beneficiaries, 2.96% among male beneficiaries and increased with age from 0.20% for ages 2-17 years, to 11.66% for individuals aged 50+ years. Annual prevalence increased from 0.8% to 3.0% overall, from 1.4% to 4.5% in female beneficiaries, and from 0.3% to 1.6% in male beneficiaries. Annual prevalence increased across age groups starting at age 18-39, 0.1%-0.6%, to age 50+, 1.8%-6.0%. Annual incidence increased from 0.6% to 0.9% overall, from 0.8% to 1.2% in female beneficiaries, and from 0.3% to 0.6% in male beneficiaries. Across age groups, annual incidence increased starting at age 18-39 (0.2%-0.3%), to age 50+ (1.0%-1.6%). CONCLUSIONS: DED overall prevalence, annual prevalence, and incidence were found to increase over time for all demographics. These findings highlight the continued importance of research and therapeutic development for this common condition.
引用
- Dana R, Bradley JL, Guerin A, et al. Estimated Prevalence and Incidence of Dry Eye Disease Based on Coding Analysis of a Large, All-age United States Health Care System. Am J Ophthalmol. 2019. PMID: 30721689. doi:10.1016/j.ajo.2019.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。